Skip to main content
Premium Trial:

Request an Annual Quote

Novacyt, AstraZeneca, GSK, University of Cambridge Partner to Increase SARS-CoV-2 Testing in UK

NEW YORK – Novacyt announced Wednesday it is partnering with AstraZeneca, GlaxoSmithKline, and the University of Cambridge to increase SARS-CoV-2 testing in the United Kingdom.

The collaboration is in support of a so-called "five pillar plan" from the UK to increase testing for the coronavirus. 

AstraZeneca, GSK, and Cambridge are setting up a new testing laboratory at the university to provide high-throughput screening for SARS-CoV-2 testing. The lab will also explore using alternative chemical reagents for diagnostic tests to alleviate current supply shortages.

Novacyt will "ensure an effective workflow process within the facility" for testing and will provide its SARS-CoV-2 test for results data, the company said. The Genesig Real-Time PCR COVID-19 test was developed by Novacyt's Southampton, UK-based molecular diagnostics division Primerdesign and received CE marking in February. The US Food and Drug Administration granted Emergency Use Authorization for the test last month. 

The test was also listed as eligible for World Health Organization procurement for one year under the agency's Emergency Use Listing process Wednesday.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.